LABORATORY RESEARCH Molecular Circuit Involving KLK4 Integrates Androgen and mTOR Signaling in Prostate Cancer Researchers showed that proteins encoded by two androgen-regulated genes, kallikrein related peptidase 4 (KLK4) and promyelocytic leukemia zinc finger, integrate optimal functioning of androgen receptor and mammalian target of rapamycin (mTOR) signaling in prostate cancer (PCa) cells. KLK4 knockdown results in a significant decline in PCa cell proliferation in vitro and in vivo, decreases anchorage-independent growth, induces apoptosis, and dramatically sensitizes PCa cells to apoptosis-inducing agents. [Proc Natl Acad Sci USA] Abstract Regulation of the Transcriptional Coactivator FHL2 Licenses Activation of the Androgen Receptor in Castrate-Resistant Prostate Cancer Scientists identified FHL2 as a novel coactivator of ligand-independent androgen-receptor (AR) variants that are important in castrate-resistant prostate cancer. They demonstrated that the nuclear localization of FHL2 and coactivation of the AR is driven by calpain-cleavage of the cytoskeletal protein filamin, a pathway which shows differential activation in prostate epithelial versus prostate cancer cell lines. [Cancer Res] Abstract Infiltrating Bone Marrow Mesenchymal Stem Cells Increase Prostate Cancer Stem Cell Population and Metastatic Ability via Secreting Cytokines to Suppress Androgen Receptor Signaling Scientists showed that prostate cancer (PCa) cells could recruit bone marrow mesenchymal stem cells and consequently the metastatic ability of PCa cells was increased. They also found that the increased metastatic ability of PCa cells could be due to the increased PCa stem cell population. [Oncogene] Abstract Id4 Deficiency Attenuates Prostate Development and Promotes PIN-Like Lesions by Regulating Androgen Receptor Activity and Expression of NKX3.1 and PTEN Scientists investigated the effect of loss of inhibitor of differentiation 4 (Id4-/-) on adult prostate morphology. Id4-/- mice had smaller prostates with fewer tubules, smaller tubule diameters and subtle mPIN like lesions. Prostate cancer cell line models in which Id4 was either silenced or over-expressed confirmed that Id4 regulates NKX3.1, Sox9 and PTEN. [Mol Cancer] Abstract | Full Article Lin28 Promotes Growth of Prostate Cancer Cells and Activates the Androgen Receptor Having previously demonstrated the importance of the Lin28/let-7/Myc axis in prostate cancer (CaP), researchers tested the hypothesis that Lin28 is overexpressed in CaP and that it activates androgen receptor and promotes growth of CaP cells. They found that Lin28 is overexpressed in clinical CaP compared to benign prostates. [Am J Pathol] Abstract Metallothionein 3: An Androgen-Upregulated Gene Enhances Cell Invasion and Tumorigenesis of Prostate Carcinoma Cells Researchers determined the effects of androgen, cadmium, and arsenic on metallothionein (MT)1/2 and MT3 in prostate carcinoma cells, and evaluated the functional effects of MT3 on cell proliferation, invasion, and tumorigenesis. Androgen, cadmium, and arsenic treatments enhanced gene expression of MT1/2 and MT3 in prostate carcinoma LNCaP cells. [Prostate] Abstract TLR7 Expression Is Decreased During Tumor Progression in Transgenic Adenocarcinoma of Mouse Prostate Mice and Its Activation Inhibits Growth of Prostate Cancer Cells The authors examined the expression of toll-like receptor (TLR)7 during tumor progression of transgenic mouse model for prostate cancer mice and its role on cell growth. Strong expression of TLR7 was detected in the normal prostate epithelia of wild-type mice, but not in TLR7-deficient mice. In contrast, TLR7 expression was weak in transgenic adenocarcinoma of mouse prostate-C2 cells, as compared with murine bone marrow-derived macrophages. [Am J Reprod Immunol] Abstract Androgen Receptors Expressed by Prostatic Stromal Cells Obtained from Younger versus Older Males Exhibit Opposite Roles in Prostate Cancer Progression Using a gene knockdown technique and coculture system, investigators found that the knockdown of the androgen receptor (AR) in prostatic stromal cells obtained from younger males could promote the invasiveness and metastasis of cocultured PC3/LNCaP cells in vitro. By contrast, the invasiveness and metastasis of LNCaP cells was inhibited when cocultured with prostatic stromal cells from older males where AR expression was knocked down. [Asian J Androl] Full Article CLINICAL RESEARCH African American Men with Very Low-Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes after Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them? To explore whether race-based health disparities exist among men with very low-risk prostate cancer (PCa), the authors evaluated oncologic outcomes of African American (AA) men with very low-risk PCa who were candidates for active surveillance but elected to undergo radical prostatectomy (RP). AA men with very low-risk PCa had more adverse pathologic features at RP and poorer oncologic outcomes. [J Clin Oncol] Abstract Role of Engrailed-2 (EN2) as a Prostate Cancer Detection Biomarker in Genetically High Risk Men Controversy surrounds the use of PSA as a biomarker for prostate cancer detection, leaving an unmet need for a novel biomarker in this setting; urinary EN2 may identify individuals with clinically relevant prostate cancer. Urine samples from 413 BRCA1 and BRCA2 mutation carriers and controls were evaluated. There was no statistically significant difference in EN2 levels according to genetic status or Gleason score. [Sci Rep] Full Article |